Search by Drug Name or NDC
NDC 00591-5713-01 Amoxapine 25 mg/1 Details
Amoxapine 25 mg/1
Amoxapine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is AMOXAPINE.
MedlinePlus Drug Summary
Amoxapine is used to treat depression. Amoxapine is in a class of medications called tricyclic antidepressants (TCAs). It works by increasing the amounts of certain natural substances in the brain that are needed to maintain mental balance.
Related Packages: 00591-5713-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Amoxapine
Product Information
| NDC | 00591-5713 |
|---|---|
| Product ID | 0591-5713_031890ec-0687-47cd-8046-6cdae8943311 |
| Associated GPIs | 58200020000305 |
| GCN Sequence Number | 046083 |
| GCN Sequence Number Description | amoxapine TABLET 25 MG ORAL |
| HIC3 | H2U |
| HIC3 Description | TRICYCLIC ANTIDEPRESSANTS,REL.NON-SEL.REUPT-INHIB |
| GCN | 16559 |
| HICL Sequence Number | 001648 |
| HICL Sequence Number Description | AMOXAPINE |
| Brand/Generic | Generic |
| Proprietary Name | Amoxapine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Amoxapine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | AMOXAPINE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Tricyclic Antidepressant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA072691 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-5713-01 (00591571301)
| NDC Package Code | 0591-5713-01 |
|---|---|
| Billing NDC | 00591571301 |
| Package | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5713-01) |
| Marketing Start Date | 1992-08-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |